Xtant Medical
Belgrade
About Xtant Medical
Xtant Medical, a medical company, manufactures, markets, and develops regenerative medicine products and medical devices for international and domestic markets. Bacterin International and X-spine Systems have combined to form XTANT Medical (NYSE MKT: XTNT), a comprehensive supplier of orthopedic and spine surgery products. Pairing the orthobiologics line-up of Bacterin with the hardware suite of X-spine, the union creates an extensive portfolio of complementary products that serve the needs of the orthopedic and neurosurgery markets, with minimal overlap. The combined company has an expanded national footprint of over 300 field sales representatives and more than 50 national accounts and regional health systems/IDN contracts, positioning XTANT Medical as a strong competitor in the spine surgery marketplace. With both Bacterin and X-spine operating units healthy and thriving, the resulting synergy increases the potential for accelerated growth and market penetration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $281.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2024)
- Ticker: nysemkt:XTNT
- Website: xtantmedical.com
- Phone: (406)-388-0480
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/xtant-medical-27850 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.